Merck & Co., Inc., Kenilworth, NJ, USA

Pharmaceutical

Merck & Co., Inc., Kenilworth, NJ, USA* donates Mectizan for the elimination of onchocerciasis as a public health problem in Africa, Latin America, and Yemen. For the elimination of lymphatic filariasis in Africa and Yemen where onchocerciasis is co-endemic, Mectizan is co-administered with albendazole, which is donated by GlaxoSmithKline. Through the generosity and commitment to improving global health and increasing access to medicines, Merck & Co., Inc., Kenilworth, NJ, USA has provided more than one billion treatments for onchocerciasis and lymphatic filariasis. Both companies also provide support for program implementation where necessary.

*Merck & Co., Inc., Kenilworth, NJ, USA is known as MSD outside North America.

www.merckresponsibility.com